Related Experiment Video

Updated: Mar 9, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

11.1K

Serum Cytokine Profiles in Children with Crohn's Disease

Ekaterina Vasilyeva1, Sayar Abdulkhakov2, Georgi Cherepnev3

  • 1Volga Region Federal Medical Research Center of the Ministry of Public Health, Nizhny Novgorod, Russia.

Mediators of Inflammation
|January 11, 2017
PubMed

Insights

Researchers found age-dependent differences in serum cytokine profiles for Crohn's disease (CD) patients. Juvenile CD patients showed higher TNF-α and IL-6, while adults had increased GM-CSF and IFN-γ during acute stages.

Area of Science:

  • Immunology
  • Gastroenterology
  • Biochemistry

Background:

  • Crohn's disease (CD) is a chronic inflammatory bowel disease with varying progression based on age at diagnosis.
  • Immune mechanisms, particularly cytokines, are implicated in CD pathogenesis.
  • Limited understanding exists regarding age-dependent differences in serum cytokine profiles in CD patients.

Purpose of the Study:

  • To investigate age-dependent differences in serum cytokine profiles between juvenile and adult Crohn's disease patients.
  • To identify specific cytokines associated with disease activity and remission in different age groups.

Main Methods:

  • Multiplex technology was utilized to analyze serum levels of 12 cytokines.
  • Serum samples were collected from juvenile and adult CD patients during acute and remission stages.
  • Cytokine levels were compared between juvenile and adult patient groups.

Main Results:

  • All CD patients exhibited elevated CXCL10 levels during acute disease, persisting into remission.
  • Juvenile CD patients showed increased serum levels of TNF-α and IL-6 during the acute stage.
  • Adult CD patients displayed upregulated levels of GM-CSF and IFN-γ during the acute stage.

Conclusions:

  • Significant age-dependent differences in serum cytokine profiles exist in Crohn's disease.
  • These distinct cytokine patterns may influence the pathogenesis of CD differently in juvenile versus adult patients.
  • Further research into these age-specific profiles could inform tailored therapeutic strategies.

More Related Videos

Bead Based Multiplex Assay for Analysis of Tear Cytokine Profiles09:22

Bead Based Multiplex Assay for Analysis of Tear Cytokine Profiles

Published on: October 13, 2017

12.4K
Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis09:44

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Published on: October 14, 2025

562

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.4K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
675
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
621
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
991
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
588